BGI Overview
Company Headquarters: Shenzhen, China
Founded: 1999
Workforce: ~3150
Company Working: BGI is a publicly listed commercial genomics company. It is one of the leading life science and genomics organizations. The company has world-leading bio-informatics research and development, large scale computing infrastructure for data output and storage, and proprietary sequencing platforms. It operates through molecular genetics, sequencing services, mass spec, and pharma solutions. It offers a wide range of integrated genomic and proteomic services and solutions for medical institutions, research institutions, and other public and private partners. BGI offers its genomics and proteomics services in research areas, such as cancer, metagenomics, drug discovery, reproductive health, and biomarker discovery. It has a presence in more than 100 countries and regions around the world and has a large network of service laboratories in China, Hong Kong, the US, and Europe.
Strategy
BGI’s mission is to leverage its genomics expertise to advance life science research and improve human health. It focuses on providing solutions in prenatal screening, hereditary cancer screening, and testing for rare diseases. Its regulatory standard-certified laboratories are committed to offering high-quality products for greater customer support.
